Filing Details

Accession Number:
0000902664-17-002616
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-12 18:45:27
Reporting Period:
2017-06-08
Filing Date:
2017-06-12
Accepted Time:
2017-06-12 18:45:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1163846 Adage Capital Partners, L.p. 200 Clarendon Street, 52Nd Floor
Boston MA 02116
No No Yes No
1165408 Adage Capital Partners Gp, L.l.c. 200 Clarendon Street, 52Nd Floor
Boston MA 02116
No No Yes No
1403403 Adage Capital Advisors, L.l.c. 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
1403404 Robert Atchinson 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
1403413 Phillip Gross 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 ("Common Stock") Disposition 2017-06-08 89,538 $80.88 3,854,302 No 4 S Indirect See footnote
Common Stock Disposition 2017-06-08 10,462 $81.49 3,843,840 No 4 S Indirect See footnote
Common Stock Disposition 2017-06-09 34,206 $80.41 3,809,634 No 4 S Indirect See footnote
Common Stock Disposition 2017-06-09 24,110 $81.29 3,785,524 No 4 S Indirect See footnote
Common Stock Disposition 2017-06-12 77,247 $79.19 3,708,277 No 4 S Indirect See footnote
Common Stock Disposition 2017-06-12 11,697 $80.08 3,696,580 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.4 to $81.375, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  2. The securities to which this filing relates are held directly by Adage Capital Partners, L.P., a Delaware limited partnership (the "Fund"). Adage Capital Partners GP, L.L.C., a Delaware limited liability company ("ACPGP"), serves as the general partner of the Fund and as such has discretion over the portfolio securities beneficially owned by the Fund. Adage Capital Advisors, L.L.C., a Delaware limited liability company ("ACA"), is the managing member of ACPGP and directs ACPGP's operations. Robert Atchinson and Phillip Gross are the managing members of ACPGP and ACA and general partners of the Fund. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of the reporting person's pecuniary interest in the securities.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.4 to $81.7, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80 to $80.95, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81 to $81.5, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  6. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.7 to $79.65, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  7. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.7 to $80.4, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.